Soumya Chakravarty, MD, PhD

Johnson & Johnson; Drexel University College of Medicine

Poster(s):

• P3167 - Inhibition of Structural Damage Progression With Guselkumab in Participants With Active Psoriatic Arthritis: Results Through Week 24 of the Phase 3b, Randomized, Double-Blind, Placebo-Controlled APEX Study
  Monday, October 27, 2025

  10:30 AM - 4:00 PM PDT